HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non–Small Cell Lung CancerKimio Yonesaka, Kazuhiko Nakagawa, Hisato Kawakami et al.|Clinical Cancer Research|2021Cited by 92
Proliferin-1 Ameliorates Cardiotoxin-Related Skeletal Muscle Repair in MiceHiroki Goto, Xian Wu Cheng|Stem Cells International|2021Cited by 12